drugset / Trial / NCT04118166

Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

NCT04118166 ↗

Phase 2 Completed 30 enrolled Kristen Ganjoo Bristol-Myers Squibb · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this Phase 2 study is to 1. find out if the study drugs (ipilimumab plus nivolumab) in combination with cryotherapy will help participants with metastatic or locally advanced soft tissue sarcoma;. 2. find out how safe are ipilimumab plus nivolumab given in combination with cryotherapy, and what side effects may be related to treatment. 3. find out how do the study drugs in combination with cryotherapy work in soft tissue sarcoma.

Timeline

Start
2019-10-01
Primary completion
2022-01-31
Completion
2022-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipilimumab Monoclonal antibody 1 mg/kg Other
Subject Nivolumab Monoclonal antibody 3 mg/kg Other

Indications